Carcinotech secures £1.6 million funding to expand internationally

Carcinotech has secured £1.6m in funding to accelerate commercialisation plans and expand internationally.

The medical technology start-up manufactures 3D printed tumours developed from cancer stem cells, primary cells and established cell lines.

Tricapital led the investment round, succeeding initial seed round leader Gabriel Investments, alongside Eos Advisory, SIS Ventures, Gabriel, Alba Equity and Scottish Enterprise.

Read more HERE.